Abvc Biopharma (ABVC) revenue and earnings history
Abvc Biopharma reported revenue of $296K for fiscal 2025 (year ended Dec 31, 2025), −41.9% on the year before, and net income of −$7.91M.
Over 15 years, from fiscal 2010 to fiscal 2025, revenue grew at a compound rate of +22.1% a year.
Revenue and net income, 19 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $296K−41.9% | −$7.15M | −$7.91M | −$2.99M | — | — | $4.14M | — | — | $681K | — | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Abvc Biopharma (ABVC) on OQRO.
Common questions
What was Abvc Biopharma's revenue in fiscal 2025?
$296K for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 3, 2026. That is −41.9% on fiscal 2024 ($510K).
How fast has Abvc Biopharma's revenue grown?
From $15K in fiscal 2010 to $296K in fiscal 2025: a compound annual growth rate of +22.1% over 15 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Abvc Biopharma been profitable?
It reported a net loss in 17 of the years shown (2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025). The highest net income was −$23K in fiscal 2014.
Where these figures come from
The SEC’s companyfacts data: every figure Abvc Biopharma tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.